Assessment of cannabidiol use in pets according to a national survey in the USA
Journal of Small Animal Practice · 2023
DOI: 10.1111/jsap.13619 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Small Animal Practice, 2023. Verfasst von I Corsato Alvarenga und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO, USA. Hauptthemen laut MEDLINE: Pets, Cannabidiol. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Rockies Partners LLC.
Abstract (Originalsprache)
Objectives
Conduct an online questionnaire to understand the motivations and perceptions about cannabidiol use in companion animals in the USA. Materials and Methods Data from a USA population sample who owned a pet were gathered using an online questionnaire. Perception of cannabidiol efficacy was analysed for independence against explanatory variables using the Pearson chi‐square test, followed by a binary logistic regression.
Results
A total of 1238 participants completed the survey; 356 had administered cannabidiol to their pet before. Dogs were the most prevalent pet, followed by cats (75.8 and 22.2%, respectively). Treats/chews and oils were the most common forms of cannabidiol (44.6 and 42.9%, respectively). The most prevalent condition for treating with cannabidiol was anxiety and stress (67.4%), followed by joint pain and inflammation (23%). Doses and frequency of cannabidiol used by many pet owners were inconsistent, and yet many participants perceived an improvement of their pets' condition with supplementation, with mild to no side effects. Most respondents had not given cannabidiol to their pets before due to uncertainty about its efficacy and safety. The frequency of cannabidiol administration and length of time administered were both significant for whether participants found it efficacious in treating a given condition, and this was more evident when supplementing cannabidiol for a longer time. Clinical Significance We found heterogeneity regarding cannabidiol dosage and dosing frequency. Cannabidiol was mostly perceived as safe and effective, but there is a need to conduct further research on cannabidiol long‐term tolerability and therapeutic efficacy for treating various conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO, USA.
Förderung
- Rockies Partners LLC
Zitieren
APA
Corsato Alvarenga, I., MacQuiddy, B., Duerr, F., Elam, L. H., & McGrath, S. (2023). Assessment of cannabidiol use in pets according to a national survey in the USA. Journal of Small Animal Practice. https://doi.org/10.1111/jsap.13619
Vancouver
Corsato Alvarenga I, MacQuiddy B, Duerr F, Elam LH, McGrath S. Assessment of cannabidiol use in pets according to a national survey in the USA. Journal of Small Animal Practice. 2023. doi:10.1111/jsap.13619
BibTeX
@article{CorsatoAlvarenga2023,
author = {Corsato Alvarenga, I and MacQuiddy, B and Duerr, F and Elam, L H and McGrath, S},
title = {Assessment of cannabidiol use in pets according to a national survey in the USA},
journal = {Journal of Small Animal Practice},
year = {2023},
doi = {10.1111/jsap.13619}
}
EUVIMED